Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
CTLA4IG (BMS-188667) in a phase IIB, multi-center, randomized, double-blind, placebo controlled study in rheumatoid arthritis patients receiving etanercept: Association between clinical response and key biomarkers Annual European Congress of Rheumatology Schiff, M., Genovese, M., Nuamah, I., Becker, J., Weinblatt, M. BMJ PUBLISHING GROUP. 2003: 178–178
View details for Web of Science ID 000224551400565